Evaluation of Cytocompatibility and Anti-Inflammatory Activity of Carboxyxanthones Selected by In Silico Studies
Ricardo F. Pereira, Catarina Amoedo-Leite, Sara Gimondi, Sara F. Vieira, João Handel, Andreia Palmeira, Maria Elizabeth Tiritan, Madalena M. M. Pinto, Nuno M. Neves, Helena Ferreira, Carla Fernandes · 2025
Read Evaluation of Cytocompatibility and Anti-Inflammatory Activity of Carboxyxanthones Selected by In Silico Studies by Ricardo F. Pereira, Catarina Amoedo-Leite, Sara Gimondi, Sara F. Vieira, João Handel, Andreia Palmeira, Maria Elizabeth Tiritan, Madalena M. M. Pinto, Nuno M. Neves, Helena Ferreira, Carla Fernandes (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785596.txt.
Description
Ricardo Pereira and co-authors test a family of compounds in 2025 as possible new anti-swelling drugs. The compounds, carboxyxanthones, share the shape traits of common pain and swelling drugs. Computer screening picked them first; the team then made twelve in all, two of them for the first time.
Cell tests checked both safety for cells and action on two key swelling signals. All tested compounds sat well with immune cells goaded into a swelling state, the head reports. Making them took multi-step routes through two classic build paths. A scaffold that is both cell-safe and active on swelling signals earns a place in the long hunt for gentler pain drugs.
Catalog record
| CREATOR | Ricardo F. Pereira, Catarina Amoedo-Leite, Sara Gimondi, Sara F. Vieira, João Handel, Andreia Palmeira, Maria Elizabeth Tiritan, Madalena M. M. Pinto, Nuno M. Neves, Helena Ferreira, Carla Fernandes |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |